No Data
European Equities Traded in the US as American Depositary Receipts Rise Thursday
Truist Financial Maintains Autolus Therapeutics(AUTL.US) With Buy Rating
Autolus Therapeutics (AUTL) Gets a Buy From Truist Financial
Express News | Autolus Therapeutics to Present Key Data on AUCATZYL At 2025 Tandem Meetings, Highlighting Cost Benefits and Clinical Outcomes
Autolus Therapeutics to Present Data at 2025 Tandem Meetings on AUCATZYL and Its Economic Impact Compared to CAR-T Therapies
Wells Fargo Maintains Autolus Therapeutics(AUTL.US) With Buy Rating, Maintains Target Price $8
blessings u : Thank you for sharing.
Trytosaveabit OP blessings u : you’re welcome